Data as of Mar 07
| -1.57 / -1.84%|
The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 100.50, with a high estimate of 110.00 and a low estimate of 78.00. The median estimate represents a +19.89% increase from the last price of 83.83.
The current consensus among 7 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.